Department of Hygiene, Social-Preventive Medicine & Medical Statistics, Medical School, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54124, Greece.
Department of Hygiene, Social-Preventive Medicine & Medical Statistics, Medical School, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54124, Greece.
J Clin Epidemiol. 2023 Jul;159:139-150. doi: 10.1016/j.jclinepi.2023.05.018. Epub 2023 May 26.
This study aimed to evaluate the epidemiology, reporting characteristics, and adherence to the Preferred Reporting Items for Overviews of Reviews (PRIOR) statement of overviews of reviews (overviews) of interventions in the cardiovascular field.
MEDLINE, Scopus, and the Cochrane Database of Systematic Reviews were searched from January 1, 2000, to October 15, 2020. An updated search was performed in MEDLINE, Epistemonikos, and Google Scholar up to August 25, 2022. Overviews of interventions published in English and primarily considering populations, interventions, and outcomes pertinent to the cardiovascular field were eligible. Study selection, data extraction, and PRIOR adherence assessment were performed by two authors independently.
We analyzed 96 overviews. Almost half (43/96 [45%]) were published between 2020 and 2022 and contained a median of 15 systematic reviews (SRs) (interquartile range, 9-28). The commonest title terminology was "overview of (systematic) reviews" (38/96 [40%]). Methods for handling SR overlap were reported in 24/96 (25%), methods for assessing primary study overlap in 18/96 (19%), handling of discrepant data in 11/96 (11%), and methods for methodological quality or risk of bias assessment of the primary studies within SRs in 23/96 (24%). Authors included data sharing statements in 28/96 (29%), complete funding disclosure in 43/96 (45%), protocol registration in 43/96 (45%), and conflict of interest statement in 82/96 (85%) overviews.
Insufficient reporting was identified in methodological characteristics unique in overviews' conduct and most transparency markers. Adoption of PRIOR from the research community could ameliorate overviews' reporting.
本研究旨在评估心血管领域干预措施综述的流行病学、报告特征和对综述优先报告条目(PRIOR)声明的遵循情况。
从 2000 年 1 月 1 日至 2020 年 10 月 15 日,检索了 MEDLINE、Scopus 和 Cochrane 系统评价数据库。截至 2022 年 8 月 25 日,在 MEDLINE、Epistemonikos 和 Google Scholar 中进行了更新检索。符合条件的综述为发表于英文文献中,主要考虑人群、干预措施和心血管领域相关结局的干预措施综述。两名作者独立进行了研究选择、数据提取和 PRIOR 遵循评估。
我们分析了 96 篇综述。近一半(43/96 [45%])发表于 2020 年至 2022 年期间,包含中位数为 15 篇系统评价(SRs)(四分位距,9-28)。最常见的标题术语是“(系统)综述概述”(38/96 [40%])。24/96(25%)篇综述报告了处理 SR 重叠的方法,18/96(19%)篇综述报告了评估主要研究重叠的方法,11/96(11%)篇综述报告了处理数据差异的方法,23/96(24%)篇综述报告了评估 SR 内主要研究方法学质量或偏倚风险的方法。28/96(29%)篇综述包含数据共享声明,43/96(45%)篇综述完整披露了资金来源,43/96(45%)篇综述进行了方案注册,82/96(85%)篇综述报告了利益冲突声明。
在综述实施过程中,方法学特征和大多数透明度标志物的报告不足。研究界采用 PRIOR 可以改善综述的报告。